GSK licenses linerixibat for liver disease itch to Alfasigma for $300M upfrontnews2026-03-09T10:29:43+00:00March 9th, 2026|Endpoints News|
Unconventional catalyst support promotes record green methanol synthesis from carbon dioxidenews2026-03-09T09:36:00+00:00March 9th, 2026|Chemistry World|
Roche’s big-hope breast cancer drug fails in crucial first-line trialnews2026-03-09T08:26:14+00:00March 9th, 2026|Endpoints News|
